United States · FDA National Drug Code directory

Stonarhini

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 49873-109_57efd45d-4dbc-5531-e063-6294a90a1c50
Product NDC: 49873-109
Form: TABLET
Composition / generic term: Chlorpheniramine maleate, phenylephrine
Labeler: Sato Pharmaceutical Co., Ltd.
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20011116
Source listing expiry: 20271231

Source-listed ingredients

CHLORPHENIRAMINE MALEATE — 2 mg/1
PHENYLEPHRINE HYDROCHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

4 BLISTER PACK in 1 CARTON (49873-109-01) / 6 TABLET in 1 BLISTER PACK · 49873-109-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →